- Home
- DNTH vs MSBI Comparison
DNTH vs MSBI Comparison
Compare DNTH & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MSBI
- Stock Information
- Founded
- DNTH 2015
- MSBI 1881
- Country
- DNTH United States
- MSBI United States
- Employees
- DNTH N/A
- MSBI N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MSBI Major Banks
- Sector
- DNTH Health Care
- MSBI Finance
- Exchange
- DNTH Nasdaq
- MSBI Nasdaq
- Market Cap
- DNTH 711.2M
- MSBI 578.5M
- IPO Year
- DNTH N/A
- MSBI 2016
- Fundamental
- Price
- DNTH $23.80
- MSBI $24.60
- Analyst Decision
- DNTH Strong Buy
- MSBI Hold
- Analyst Count
- DNTH 9
- MSBI 4
- Target Price
- DNTH $46.43
- MSBI $27.75
- AVG Volume (30 Days)
- DNTH 203.7K
- MSBI 78.2K
- Earning Date
- DNTH 11-07-2024
- MSBI 01-23-2025
- Dividend Yield
- DNTH N/A
- MSBI 5.04%
- EPS Growth
- DNTH N/A
- MSBI N/A
- EPS
- DNTH N/A
- MSBI 2.30
- Revenue
- DNTH $5,366,000.00
- MSBI $259,944,000.00
- Revenue This Year
- DNTH $98.73
- MSBI N/A
- Revenue Next Year
- DNTH N/A
- MSBI $0.14
- P/E Ratio
- DNTH N/A
- MSBI $10.68
- Revenue Growth
- DNTH 51.41
- MSBI N/A
- 52 Week Low
- DNTH $8.24
- MSBI $20.54
- 52 Week High
- DNTH $33.77
- MSBI $28.47
- Technical
- Relative Strength Index (RSI)
- DNTH 46.14
- MSBI 34.43
- Support Level
- DNTH $22.59
- MSBI $26.16
- Resistance Level
- DNTH $24.57
- MSBI $26.58
- Average True Range (ATR)
- DNTH 1.49
- MSBI 0.67
- MACD
- DNTH 0.04
- MSBI -0.37
- Stochastic Oscillator
- DNTH 30.84
- MSBI 14.81
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MSBI Midland States Bancorp Inc.
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.